XPH vs. PSCH
XPH (SPDR S&P Pharmaceuticals ETF) and PSCH (Invesco S&P SmallCap Health Care ETF) are both Health & Biotech Equities funds - XPH tracks the S&P Pharmaceuticals Select Industry Index while PSCH tracks the S&P SmallCap 600 Health Care Index. Both are passively managed. Over the past 10 years, XPH returned 3.44%/yr vs 6.81%/yr for PSCH. A 0.79 correlation means they provide meaningful diversification when combined. XPH charges 0.35%/yr vs 0.29%/yr for PSCH.
Performance
XPH vs. PSCH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 0.66% return, which is significantly lower than PSCH's 1.80% return. Over the past 10 years, XPH has underperformed PSCH with an annualized return of 3.44%, while PSCH has yielded a comparatively higher 6.81% annualized return.
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
PSCH
- 1D
- 1.28%
- 1M
- -0.71%
- YTD
- 1.80%
- 6M
- -1.68%
- 1Y
- 10.18%
- 3Y*
- 0.45%
- 5Y*
- -5.72%
- 10Y*
- 6.81%
XPH vs. PSCH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
PSCH Invesco S&P SmallCap Health Care ETF | 1.80% | -0.49% | 3.77% | -2.71% | -25.15% | 5.75% | 31.47% | 20.17% | 9.15% | 34.87% |
Correlation
The correlation between XPH and PSCH is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.75 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.79 |
The correlation between XPH and PSCH has been stable across timeframes, ranging from 0.74 to 0.79 - a consistent structural relationship.
XPH vs. PSCH - Sectors Allocation Comparison
Sectors
XPH
PSCH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
XPH
PSCH
Basic Materials
XPH
-
PSCH
-
Communication Services
XPH
-
PSCH
-
Consumer Cyclical
XPH
-
PSCH
-
Consumer Defensive
XPH
-
PSCH
-
Energy
XPH
-
PSCH
-
Financial Services
XPH
-
PSCH
Industrials
XPH
-
PSCH
Real Estate
XPH
-
PSCH
-
Technology
XPH
-
PSCH
Utilities
XPH
-
PSCH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. PSCH — Risk / Return Rank
XPH
PSCH
XPH vs. PSCH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | PSCH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.27 | ||
| Sortino ratioReturn per unit of downside risk | +1.64 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.10 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 3.19 | 0.67 | +2.52 |
| Martin ratioReturn relative to average drawdown | 11.37 | 1.84 | +9.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XPH | PSCH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | 0.51 | +1.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | -0.25 | +0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.29 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.51 | -0.13 |
Drawdowns
XPH vs. PSCH - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, roughly equal to the maximum PSCH drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for XPH and PSCH.
Loading charts...
Drawdown Indicators
| XPH | PSCH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -46.32% | -1.71% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -15.36% | +3.39% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -22.98% | -0.59% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -46.32% | +14.69% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -46.32% | +10.35% |
Current DrawdownCurrent decline from peak | -7.22% | -30.59% | +23.37% |
Average DrawdownAverage peak-to-trough decline | -17.25% | -13.46% | -3.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.35% | 5.54% | -2.19% |
Volatility
XPH vs. PSCH - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.03% compared to Invesco S&P SmallCap Health Care ETF (PSCH) at 4.19%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | PSCH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.03% | 4.19% | +2.84% |
Volatility (6M)Calculated over the trailing 6-month period | 16.77% | 14.06% | +2.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.52% | 20.26% | +1.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.84% | 22.89% | -2.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.10% | 23.63% | -1.53% |
XPH vs. PSCH - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is higher than PSCH's 0.29% expense ratio.
Dividends
XPH vs. PSCH - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.66%, more than PSCH's 0.01% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and PSCH have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.03%) compared to PSCH (4.19%). In terms of maximum drawdown, XPH dropped -48.03% vs PSCH's -46.32%.
On 10-year performance, PSCH leads with 6.81% vs 3.44% for XPH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.19%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PSCH has performed better with a 6.81% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PSCH is cheaper with a 0.29% expense ratio, compared with 0.35% for XPH.
XPH has the higher dividend yield at 0.66%, compared with 0.01% for PSCH.
XPH tracks S&P Pharmaceuticals Select Industry Index, while PSCH tracks S&P SmallCap 600 Health Care Index. They also come from different issuers: State Street and Invesco. Their fees differ too: 0.35% for XPH and 0.29% for PSCH.
XPH currently has the higher Sharpe Ratio (1.77 vs 0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and PSCH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer